Poster & Publications

Improve Molecular Residual Disease monitoring by combining ctDNA molecular profiling and circulating H3K27Me3-nucleosome levels

March 05, 2024

Share
Tweet
Share on Facebook
Share

Poster titled: “Improve Molecular Residual Disease monitoring by combining ctDNA molecular profiling and circulating H3K27Me3-nucleosome levels in NSCLC plasma samples.”

Presented at CNAPS 2024

Grolleau et al

Download

Poster & Publications
Circulating H3K27me3 modified nucleosomes as a biomarker to monitor anti EZH2-based treatment in advanced solid tumour patients
Poster & Publications
Novel ctDNA technology for early cancer detection by immunoprecipitation of tumor associated ctDNA fragments and analysis by qPCR

Share
Tweet
Share on Facebook
Share

Subscribe for Volition product updates.

Or, click here for Investor Updates and press releases.

"*" indicates required fields

Receive product updates for:

Animal Health

Human Health

Name

First Name Last Name

Company Name*

Your Email Address*

CAPTCHA

Improve Molecular Residual Disease monitoring by combining ctDNA molecular profiling and circulating H3K27Me3-nucleosome levels

Related Articles

Circulating H3K27me3 modified nucleosomes as a biomarker to monitor anti EZH2-based treatment in advanced solid tumour patients

Novel ctDNA technology for early cancer detection by immunoprecipitation of tumor associated ctDNA fragments and analysis by qPCR

Subscribe for Volition product updates.

Or, click here for Investor Updates and press releases.

Contact